Anti-CPP predicts RA drug response

Personalised medicine is a step closer for RA patients with the announcement at EULAR that the presence of anti-CPP antibody is associated with a better response to the drug abatacept.

It is known that being positive for anti-CPP antibody is associated with more severe rheumatoid arthritis and that these patients do less well on treatments with a combination of non-biologic DMARDS and steroids.

But now US

Latest

Trending